Syndax Pharmaceuticals (1T3.F) Q4 2025 Earnings

3NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.11
-0.94
-0.77
-0.61

Details

Expected EPS
-0.62886022485
Actual EPS
-0.6076069999999999
Surprise EPS
0.02
Surprise Percent
+3.38%

Description

Syndax Pharmaceuticals (1T3.F) has reported earnings of -0.6076069999999999 per share for Q4 2025.

0 Comments

Share your thoughts